A longitudinal study of inflammation, CKD-mineral bone disorder, and carotid atherosclerosis after renal transplantation

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 3, 2015, Pages 471-479

  Yilmaz, Mahmut Ilker ^a   Sonmez, Alper ^a   Saglam, Mutlu ^a   Cayci, Tuncer ^a   Kilic, Selim ^a   Unal, Hilmi Umut ^a   Karaman, Murat ^a   Cetinkaya, Hakki ^a   Eyileten, Tayfun ^a   Gok, Mahmut ^a   Oguz, Yusuf ^a   Vural, Abdulgaffar ^a   Mallamaci, Francesca ^a,b   Zoccali, Carmine ^c  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Departments of Nephrology Hypertension and Renal Transplantation   (Italy)

^c BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CALCINEURIN INHIBITOR; CALCIUM; CYCLOSPORIN; FIBROBLAST GROWTH FACTOR 23; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHATE; PREDNISOLONE; TACROLIMUS; TRIACYLGLYCEROL; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR; PARATHYROID HORMONE;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; BONE DISEASE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; BLOOD; BLOOD PRESSURE; CAROTID ARTERY DISEASE; COMPLICATION; DIAGNOSTIC IMAGING; INFLAMMATION; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDY; METABOLIC BONE DISEASE; METABOLISM; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; YOUNG ADULT;

ADULT; BIOMARKERS; BLOOD PRESSURE; BONE DISEASES, METABOLIC; C-REACTIVE PROTEIN; CALCIUM; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; FIBROBLAST GROWTH FACTORS; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; PARATHYROID HORMONE; PHOSPHATES; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; YOUNG ADULT;

EID: 84924416734     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.07860814     Document Type: Article

References (37)

1. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, Held PJ, Port FK: Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 341: 1725–1730, 1999.
2. Hunsicker LG: A survival advantage for renal transplantation. N Engl J Med 341: 1762–1763, 1999.
3. vanDijk PC, Jager KJ, de Charro F, Collart F, Cornet R, Dekker FW, Grönhagen-Riska C, Kramar R, Leivestad T, Simpson K, Briggs JD; ERA-EDTA registry: Renal replacement therapy in Europe: The results of a collaborative effort by the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant 16: 1120–1129, 2001.
4. Kasiske BL, Chakkera HA, Roel J: Explained and unexplained ischemic heart disease risk after renal transplantation. J Am Soc Nephrol 11: 1735–1743, 2000.
5. Stenvinkel P, Wanner C, Metzger T, Heimbürger O, Mallamaci F, Tripepi G, Malatino L, Zoccali C: Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage? Kidney Int 62: 1791–1798, 2002.
6. Benedetto FA, Tripepi G, Mallamaci F, Zoccali C: Rate of atherosclerotic plaque formation predicts cardiovascular events in ESRD. J Am Soc Nephrol 19: 757–763, 2008.
7. Hruska KA, Mathew S, Lund RJ, Memon I, Saab G: The pathogenesis of vascular calcification in the chronic kidney disease mineral bone disorder: The links between bone and the vasculature. Semin Nephrol 29: 156–165, 2009.
8. London GM, Guérin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F: Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18: 613–620, 2007.
9. Simmons EM, Langone A, Sezer MT, Vella JP, Recupero P, Morrow JD, Ikizler TA, Himmelfarb J: Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation 79: 914–919, 2005.
10. Molnar MZ, Naser MS, Rhee CM, Kalantar-Zadeh K, Bunnapradist S: Bone and mineral disorders after kidney transplantation: Therapeutic strategies. Transplant Rev (Orlando) 28: 56–62, 2014.
11. Kidney Disease: Improving Global Outcomes (KDIGO) CKDMBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 113: S1–S130, 2009.
12. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, Najjar SS, Rembold CM, Post WS; American Society of Echocardiography Carotid Intima-Media Thickness Task Force; Endorsed by the Society for Vascular Medicine: Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: A consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. J Am Soc Echocardiogr 21: 93–111, quiz 189–190, 2008.
13. Tardif JC, Heinonen T, Orloff D, Libby P: Vascular biomarkers and surrogates in cardiovascular disease. Circulation 113: 2936–2942, 2006.
14. European Medicines Agency: Pre-Authorisation Evaluation of Medicines for Human Use. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003242.pdf. Accessed January 10, 2010.
15. Szeto CC, Chow KM, Woo KS, Chook P, Ching-Ha Kwan B, Leung CB, Kam-Tao Li P: Carotid intima media thickness predicts cardiovascular diseases in Chinese predialysis patients with chronic kidney disease. J Am Soc Nephrol 18: 1966–1972, 2007.
16. Benedetto FA, Mallamaci F, Tripepi G, Zoccali C: Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol 12: 2458–2464, 2001.
17. Suwelack B, Gerhardt U, Witta J, Hillebrandt U, Hohage H: Effect of parathyroid hormone levels on carotid intima-media thickness after renal transplantation. Am J Hypertens 14: 1012–1018, 2001.
18. Wolf M: Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int 82: 737–747, 2012.
19. Meier-Kriesche HU, Schold JD, Srinivas TR, Reed A, Kaplan B: Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease. AmJ Transplant 4: 1662–1668, 2004.
20. Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Turker T, Unal HU, Gok M, Cetinkaya H, Eyileten T, Oguz Y, Caglar K, Vural A, Mallamaci F, Zoccali C: Longitudinal analysis of vascular function and biomarkers of metabolic bone disorders before and after renal transplantation. Am J Nephrol 37: 126–134, 2013.
21. Joannides R, Etienne I, Iacob M, Hurault de Ligny B, Barbier S, Bellien J, Lebranchu Y, Thuillez C, Godin M: Comparative effects of sirolimus and cyclosporin on conduit arteries endothelial function in kidney recipients. Transpl Int 23: 1135–1143, 2010.
22. Seckinger J, Sommerer C, Hinkel UP, Hoffmann O, Zeier M, Schwenger V: Switch of immunosuppression from cyclosporine A to everolimus: Impact on pulse wave velocity in stable de-novo renal allograft recipients. J Hypertens 26: 2213–2219, 2008.
23. Beiras-Fernandez A, Walther S, Thein E, Muenzing S, Hammer C: Influence of polyclonal ATGs on expression of adhesion molecules: An experimental study. Transplant Proc 37: 1944–1946, 2005.
24. Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Demirkaya E, Eyileten T, Caglar K, Oguz Y, Vural A, Yenicesu M, Zoccali C: FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease. Kidney Int 78: 679–685, 2010.
25. Kleinbaum DG, Kupper LL, Muller KE, Nizam A: Applied Regression Analysis and Other Multivariable Methods, Boston, Duxbury Press, 1998, pp 389–390.
26. Kasiske BL, Guijarro C, Massy ZA, Wiederkehr MR, Ma JZ: Cardiovascular disease after renal transplantation. J AmSoc Nephrol 7: 158–165, 1996.
27. Kalantar-Zadeh K, Molnar MZ, Kovesdy CP, Mucsi I, Bunnapradist S: Management of mineral and bone disorder after kidney transplantation. Curr Opin Nephrol Hypertens 21: 389–403, 2012.
28. Cañas L, Bayés B, Granada ML, Ibernon M, Porrini E, Benítez R, Díaz JM, Lauzurica R, Moreso F, Torres A, Lampreabe I, Serra A, Romero R: Is adiponectin a marker of preclinical atherosclerosis in kidney transplantation? Clin Transplant 26: 259–266, 2012.
29. Turkmen K, Tonbul HZ, Erdur FM, Toker A, Biyik Z, Ozbiner H, Gaipov A, Gul EE, Kayrak M, Solak Y, Ozbek O, Turk S, Covic A: Soluble TWEAK independently predicts atherosclerosis in renal transplant patients. BMC Nephrol 14: 144, 2013.
30. Uchida J, Machida Y, Iwai T, Kuwabara N, Kabei K, Naganuma T, Kumada N, Nakatani T: Glucose intolerance is associated with increased intimal-medial thickness of the carotid artery and increased pulse-wave velocity in renal transplant recipients. Transplant Proc 45: 1535–1539, 2013.
31. Cobanoglu AK, Gungor O, Kircelli F, Altunel E, Asci G, Ozbek SS, Toz H, Ok E: Role of asymmetric dimethylarginine in the progression of carotid atherosclerosis in renal transplant patients. Int Urol Nephrol 45: 1463–1469, 2013.
32. Gungor O, Kismali E, Sisman AR, Kircelli F, Carrero JJ, Tatar E, Asci G, Toz H: The relationships between serum sTWEAK, FGF-23 levels, and carotid atherosclerosis in renal transplant patients. Ren Fail 35: 77–81, 2013.
33. Grootendorst DC, Jager KJ, Zoccali C, Dekker FW: Observational studies are complementary to randomized controlled trials. Nephron Clin Pract 114: c173–c177, 2010.
34. Liuba P, Persson J, Luoma J, Ylä-Herttuala S, Pesonen E: Acute infections in children are accompanied by oxidative modification of LDL and decrease ofHDL cholesterol, and are followed by thickening of carotid intima-media. Eur Heart J 24: 515–521, 2003.
35. Mirza MA, Hansen T, Johansson L, Ahlström H, Larsson A, Lind L, Larsson TE: Relationship between circulating FGF23 and total body atherosclerosis in the community. Nephrol Dial Transplant 24: 3125–3131, 2009.
36. Serdengecti K, Suleymanlar G, Altiparmak MR, Seyahi N: Turkish Registry of Dialysis and Transplantation. Available at: http://tsn.org.tr/folders/file/registry%20kitap.pdf. Accessed March 25, 2010.
37. Munoz Mendoza J, Isakova T, Ricardo AC, Xie H, Navaneethan SD, Anderson AH, Bazzano LA, Xie D, Kretzler M, Nessel L, Hamm LL, Negrea L, Leonard MB, Raj D, Wolf M; Chronic Renal Insufficiency Cohort: Fibroblast growth factor 23 and Inflammation in CKD. Clin J Am Soc Nephrol 7: 1155–1162, 2012.